Welcome to
Sysmex Flow Cytometry Austria!

For ordering please make sure you are in your local shop.
If you are from Austria then please continue.
Otherwise please go to your country.

Go to my country Continue

CyFlow™ CD81 FITC

CyFlow™ CD81 FITC
Antigen: CD81
Alternative Name: TAPA-1
Clone: M38
Application: Flow cytometry
Format/Fluorochrome: FITC
Laser: Blue
Target Species: Cat, Human, Rabbit
Field of Interest: Immunophenotyping
Species of Origin: Mouse
Regulatory Status: RUO
Clonality: monoclonal
Emission Maximum: 518 nm
Excitation Maximum: 490 to 495 nm
Isotype: IgG1
Order number: CU428000

For Research Use Only
Not for use in diagnostic or therapeutic procedures.

Quantity 100 tests Volume 2 ml Immunogen MOLT-4 (human T-ALL cell line) Specifity... more
CyFlow™ CD81 FITC
Quantity100 tests
Volume2 ml
ImmunogenMOLT-4 (human T-ALL cell line)
SpecifityThe mouse monoclonal antibody M38 recognizes CD81 antigen, a 25 kDa member of the tetraspanin family, expressed on majority of cells.
Background InformationCD81 (TAPA-1), a member of the tetraspanin family, is expressed on virtually all nucleated cells, but above all on germinal center B cells. CD81 forms complexes with other tetraspanin proteins, integrins, coreceptors, MHC class I and II molecules, and influences adhesion, morphology, activation, proliferation and differentiation of B, T and other cells, e.g. in muscles CD81 promotes cell fusion and myotube maintenance. CD81 has been also identified as a receptor for the hepatitis C virus.
UsageThe reagent is designed for Flow Cytometry analysis of human blood cells. Recommended usage is 20·µl reagent·/ 100·µl of whole blood or 10^6 cells in a suspension. The content of a vial (2 ml) is sufficient for 100 tests.
Storage BufferThe reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.1% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.

Article successfully added.